Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL

Pratima Sinha, Olesya Chornoguz, Virginia K. Clements, Konstantin A. Artemenko, Roman A. Zubarev, Suzanne Ostrand-Rosenberg

Blood (2011) 117 (20): 5381–5390.

https://doi.org/10.1182/blood-2010-11-321752

Published: 2011

Includes: Supplemental data

Journal Articles

Low CLIP Expression On Leukemic Blasts From AML Patients Is Essential for the Generation of Effective CD4 + T Cell Responses.

Marvin M. van Luijn, Martine E.D. Chamuleau, MD, PhD, James A. Thompson, Suzanne Ostrand-Rosenberg, PhD, Theresia M. Westers, PhD, Yuri Souwer, Gert J. Ossenkoppele, MD, PhD, S. Marieke van Ham, PhD, Arjan A. van de Loosdrecht, MD, PhD

Blood (2009) 114 (22): 996.

https://doi.org/10.1182/blood.V114.22.996.996

Published: 2009

Journal Articles

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

Marvin M. van Luijn, Martine E.D. Chamuleau, MD, PhD, Maaike E. Ressing, PhD, Emmanuel J.H.J. Wiertz, PhD, Suzanne Ostrand-Rosenberg, PhD, Yuri Souwer, Adri Zevenbergen, Gert J. Ossenkoppele, MD, PhD, Arjan A. van de Loosdrecht, MD, PhD, S. Marieke van Ham, PhD

Blood (2009) 114 (22): 3114.

https://doi.org/10.1182/blood.V114.22.3114.3114

Published: 2009

Journal Articles

TAP- and Proteasome-Dependent Endogenous Antigen Loading of HLA Class II in Leukemic Blasts Introduces a Promising New Target for Generating Leukemia-Specific CD4 + T Cells

Marvin M. van Luijn, MSc, Maaike E. Ressing, PhD, Emmanuel J.H.J. Wiertz, PhD, Adri Zevenbergen, Martine E.D. Chamuleau, MD, Yuri Souwer, MSc, Suzanne Ostrand-Rosenberg, PhD, Gert J. Ossenkoppele, MD, PhD, Arjan A. van de Loosdrecht, MD, PhD, S. Marieke van Ham, PhD

Blood (2008) 112 (11): 5443.

https://doi.org/10.1182/blood.V112.11.5443.5443

Published: 2008

Journal Articles

Modification of Invariant Chain and CLIP Expression Increases the Immunogenicity of Leukemic Blasts to Potentiate Leukemia-Specific T Cell Reactivity

Marvin M. van Luijn, MSc, Martine E.D. Chamuleau, MD, James A. Thompson, PhD, Suzanne Ostrand-Rosenberg, PhD, Theresia M. Westers, PhD, Yuri Souwer, MSc, Gert J. Ossenkoppele, MD, PhD, S. Marieke van Ham, PhD, Arjan A. van de Loosdrecht, MD, PhD

Blood (2008) 112 (11): 5430.

https://doi.org/10.1182/blood.V112.11.5430.5430

Published: 2008

Journal Articles

Class-II Associated Invariant Chain Peptide (CLIP) Expression on AML Blasts Adversely Affects Alloreactive CD4 + T Cell Recognition.

Marvin M. van Luijn, MSc, Martine E.D. Chamuleau, MSc., Theresia M. Westers, James A. Thompson, MSc., Suzanne Ostrand-Rosenberg, Gert J. Ossenkoppele, S. Marieke van Ham, Arjan A. Van de Loosdrecht

Blood (2007) 110 (11): 4888.

https://doi.org/10.1182/blood.V110.11.4888.4888

Published: 2007

NARROW

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL

Low CLIP Expression On Leukemic Blasts From AML Patients Is Essential for the Generation of Effective CD4 + T Cell Responses.

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

TAP- and Proteasome-Dependent Endogenous Antigen Loading of HLA Class II in Leukemic Blasts Introduces a Promising New Target for Generating Leukemia-Specific CD4 + T Cells

Modification of Invariant Chain and CLIP Expression Increases the Immunogenicity of Leukemic Blasts to Potentiate Leukemia-Specific T Cell Reactivity

Class-II Associated Invariant Chain Peptide (CLIP) Expression on AML Blasts Adversely Affects Alloreactive CD4 + T Cell Recognition.

Email alerts

ASH Publications

American Society of Hematology

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL

Low CLIP Expression On Leukemic Blasts From AML Patients Is Essential for the Generation of Effective CD4 + T Cell Responses.

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

TAP- and Proteasome-Dependent Endogenous Antigen Loading of HLA Class II in Leukemic Blasts Introduces a Promising New Target for Generating Leukemia-Specific CD4 + T Cells

Modification of Invariant Chain and CLIP Expression Increases the Immunogenicity of Leukemic Blasts to Potentiate Leukemia-Specific T Cell Reactivity

Class-II Associated Invariant Chain Peptide (CLIP) Expression on AML Blasts Adversely Affects Alloreactive CD4 + T Cell Recognition.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only